Table 1.
Exposure | Cell type | ||||||||
---|---|---|---|---|---|---|---|---|---|
size | dose | WBC | NE | LY | MO | EO | BA | RBC | PLT |
- | - | 1.89 (0.38) | 0.760 (0.271) | 1.06 (0.20) | 0.049 (0.011) | 0.003 (0.002) | 0.001 (0.001) | 7.07 (0.75) | 768 (64.6) |
5 μm | 0.1μg/ml | 2.68 (0.59) | 1.49 (0.46) | 1.04 (0.14) | 0.091 (0.026) | 0.034* (0.011) | 0.016* (0.007) | 9.23 (0.37) | 583 (87.2) |
5 μm | 1.0 μg/ml | 2.32 (0.27) | 0.764 (0.095) | 1.39 (0.18) | 0.098* (0.015) | 0.047* (0.011) | 0.015* (0.005) | 8.07 (0.49) | 536 (73.1) |
0.5 μm | 0.1 μg/ml | 2.23 (0.45) | 0.912 (0.304) | 1.24 (0.18) | 0.074 (0.013) | 0.002 (0.001) | 0.001 (0.001) | 7.64 (0.57) | 632 (84.4) |
0.5 μm | 1.0 μg/ml | 1.69 (0.24) | 0.506 (0.137) | 1.11 (0.13) | 0.058 (0.010) | 0.006 (0.004) | 0 (0) | 7.97 (0.48) | 843 (61.3) |
Listed are cell counts in blood samples obtained from the 5 treatment groups at termination. Values are presented as average (SE). WBC: white blood cells; NE: neutrophils; LY: lymphocytes; MO: monocytes; RBC: red blood cells; PLT: platelets; EO: eosinophils; BA: basophils. Units are 103 cells per μl except for RBC which is 106 per μl.
p<0.05 vs control.